Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer
Referencias
Additional references
American Cancer Society. Chemotherapy and other drugs for pancreatic cancer. www.cancer.org/cancer/pancreatic‐cancer/treating/chemotherapy.html (accessed 20 May 2017).
Akahori T, Sho M, Tanaka T, Kinoshita S, Nagai M, Nishiwada S, et al. Factors associated with failure to complete adjuvant chemotherapy in pancreatic cancer. American Journal of Surgery 2016;211(4):787‐92. [PUBMED: 26846177]
Armstrong T, Walters E, Varshney S, Johnson CD. Deficiencies of micronutrients, altered bowel function, and quality of life during late follow‐up after pancreaticoduodenectomy for malignancy. Pancreatology 2002;2(6):528‐34. [PUBMED: 12435865]
Badger SA, Brant JL, Jones C, McClements J, Loughrey MB, Taylor MA, et al. The role of surgery for pancreatic cancer: a 12‐year review of patient outcome. Ulster Medical Journal 2010;79(2):70‐5.
Bardou M, Le Ray I. Treatment of pancreatic cancer: a narrative review of cost‐effectiveness studies. Best Practice & Research. Clinical Gastroenterology 2013;27(6):881‐92. [PUBMED: 24182608]
Bartel MJ, Asbun H, Stauffer J, Raimondo M. Pancreatic exocrine insufficiency in pancreatic cancer: a review of the literature. Digestive and Liver Disease 2015;47(12):1013‐20. [PUBMED: 26211872]
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta‐analysis. Chichester: Wiley & Sons, 2008.
Bowles MJ, Benjamin IS. Cancer of the stomach and pancreas. BMJ2001; Vol. 323, issue 7326:1413‐6. [PUBMED: 11744568]
Pancreatric Section, British Society of Gastroenterology, Pancreatic Society of Great Britain and Ireland, Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, Royal College of Pathologists, Special Interest Group for Gastro‐Intestinal Radiology. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut2005; Vol. 54, issue Suppl 5:v1‐v16. [PUBMED: 15888770]
Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GNJ, van Leeuwen DJ. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut 1998;42(1):92‐6.
Cochrane Consumers and Communication Review Group. Standard protocol text and additional guidance for review authors. cccrg.cochrane.org/sites/cccrg.cochrane.org/files/public/uploads/cccrgproto_template_revised_december_1st_2016.docx (accessed 29 January 2018).
Cheifetz AS, Brown A, Curry M, Moss AC. Oxford American Handbook of Gastroenterology and Hepatology. Oxford University Press, 2011:234.
Damerla V, Gotlieb V, Larson H, Saif MW. Pancreatic enzyme supplementation in pancreatic cancer. Journal of Supportive Oncology 2008;6(8):393‐6. [PUBMED: 19149324]
Di Luzio R, Moscatiello S, Marchesini G. Role of nutrition in gastrointestinal oncological patients. European Review for Medical and Pharmacological Sciences 2010;14(4):277‐84. [PUBMED: 20496536]
Dominguez‐Munoz JE, Iglesias‐Garcia J, Iglesias‐Rey M, Figueiras A, Vilarino‐Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three‐way crossover study. Alimentary Pharmacology & Therapeutics 2005;21(8):993‐1000. [PUBMED: 15813835]
Dorsey J, Buckley D, Summer S, Jandacek RJ, Rider T, Tso P, et al. Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid. Journal of Pediatric Gastroenterology and Nutrition 2010;50(4):441‐6.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. British Medical Journal 1997;315(7109):629‐34.
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. The Lancet. Oncology 2011;12(5):489‐95. [PUBMED: 21296615]
Ferrone M, Raimondo M, Scolapio JS. Pancreatic enzyme pharmacotherapy. Pharmacotherapy 2007;27(6):910‐20.
Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clinical and Experimental Gastroenterology2011; Vol. 4:55‐73. [PUBMED: 21753892]
Fragoso AV, Pedroso MR, Herman P, Montagnini AL. Comparing the enzyme replacement therapy cost in post pancreatectomy patients due to pancreatic tumor and chronic pancreatitis. Arquivos de Gastroenterologia 2016;53(2):94‐7.
Freelove R, Walling AD. Pancreatic cancer: diagnosis and management. American Family Physician 2006;73(3):485‐92. [PUBMED: 16477897]
Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE Handbook. gdt.guidelinedevelopment.org/app/handbook/handbook.html (accessed 29 January 2018).
GRADE Working Group, McMaster University. GRADEproGDT. Version accessed 29 January 2018. Hamilton (ON): GRADE Working Group, McMaster University, 2015.
Hidalgo M. Pancreatic cancer. New England Journal of Medicine 2010;362(17):1605‐17.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. British Medical Journal 2003;327(7414):557‐60.
Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hirono S, Murakami Y, Tani M, Kawai M, Okada K, Uemura K, et al. Identification of risk factors for pancreatic exocrine insufficiency after pancreaticoduodenectomy using a 13C‐labeled mixed triglyceride breath test. World Journal of Surgery 2015;39(2):516‐25. [PUBMED: 25318451]
Ilic M, Ilic I. Epidemiology of pancreatic cancer. World Journal of Gastroenterology 2016;22(44):9694‐705.
Imrie CW, Connett G, Hall RI, Charnley RM. Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer. Alimentary Pharmacology & Therapeutics 2010;32 Suppl 1:1‐25. [PUBMED: 21054452]
Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's Principles of Internal Medicine 19/E (Vol. 1 & Vol. 2). McGraw‐Hill Education, 2015:269, 554.
Keim V, Klar E, Poll M, Schoenberg MH. Postoperative care following pancreatic surgery: surveillance and treatment. Deutsches Arzteblatt International 2009;106(48):789‐94.
Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut 2005;54(Suppl 6):1‐28.
Lewis J A, Machin D. Intention to treat‐‐who should use ITT?. British Journal of Cancer 1993;68(4):647‐50.
Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004;363(9414):1049‐57. [PUBMED: 15051286]
Lucia S, Esposito M, Rossi Fanelli F, Muscaritoli M. Cancer cachexia: from molecular mechanisms to patient's care. Critical Reviews in Oncogenesis 2012;17(3):315‐21. [PUBMED: 22831162]
Lohr JM, Dominguez‐Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, et al. United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterology Journal 2017;5(2):153‐99. [PUBMED: 28344786]
Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta‐analysis. Statistics in Medicine 2001;20(4):641‐54. [PUBMED: 11223905]
Maitra A, Hruban RH. Pancreatic Cancer. Annual Review of Pathology2008; Vol. 3:157‐88. [PUBMED: 18039136]
MedlinePlus. Fecal fat. medlineplus.gov/ency/article/003588.htm (accessed 6 February 2018).
Meyer JH, Elashoff J, Porter‐Fink V, Dressman J, Amidon GL. Human postprandial gastric emptying of 1‐3‐millimeter spheres. Gastroenterology 1988;94(6):1315‐25. [PUBMED: 3360258]
Meyer JH, Lake R. Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres. Pancreas 1997;15(3):226‐35. [PUBMED: 9336785]
Moss AC. Evaluation of steatorrhea. us.bp.api.bmj.com/best‐practice/monograph/770/diagnosis/step‐by‐step.html (accessed 26 April 2017).
Nakajima K, Oshida H, Muneyuki T, Kakei M. Pancrelipase: an evidence‐based review of its use for treating pancreatic exocrine insufficiency. Core Evidence 2012;7:77‐91.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology Pancreatic Adenocarcinoma. www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf (accessed 17 November 2015).
Newell DJ. Intention‐to‐treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992;21(5):837‐41. [PUBMED: 1468842]
Ozola Zalite I, Zykus R, Francisco Gonzalez M, Saygili F, Pukitis A, Gaujoux S, et al. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review. Pancreatology 2015;15(1):19‐24. [PUBMED: 25524484]
National Cancer Institute. Pancreatic Cancer Treatment (PDQ)‐Patient Version. www.cancer.gov/types/pancreatic/patient/pancreatic‐treatment‐pdq. Bethesda: National Cancer Institute, (accessed 25 September 2015).
Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G, et al. Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian association for the study of the pancreas. World Journal of Gastroenterology2013; Vol. 19, issue 44:7930‐46. [PUBMED: 24307787; PUBMED: 24307787]
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Safdi M, Bekal PK, Martin S, Saeed ZA, Burton F, Toskes PP. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo‐controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas 2006;33(2):156‐62. [PUBMED: 16868481]
Seal BS, Anderson S, Shermock KM. Factors associated with adherence rates for oral and intravenous anticancer therapy in commercially insured patients with metastatic colon cancer. Journal of Managed Care & Specialty Pharmacy 2016;22(3):227‐35.
Smith RC, Smith SF, Wilson J, Pearce C, Wray N, Vo R, et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology 2016;16(2):164‐80. [PUBMED: 26775768]
Spoelstra SL, Given CW. Assessment and measurement of adherence to oral antineoplastic agents. Seminars in Oncology Nursing 2011;27(2):116‐32.
Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency ‐ breaking the myths. BMC Medicine 2017;15(1):29.
Thorat V, Reddy N, Bhatia S, Bapaye A, Rajkumar JS, Kini DD, et al. Randomised clinical trial: the efficacy and safety of pancreatin enteric‐coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis ‐ a double‐blind, placebo‐controlled study. Alimentary Pharmacology & Therapeutics2012; Vol. 36, issue 5:426‐36. [PUBMED: 22762290]
Trapnell BC, Strausbaugh SD, Woo MS, Tong SY, Silber SA, Mulberg AE, et al. Efficacy and safety of PANCREAZE(R) for treatment of exocrine pancreatic insufficiency due to cystic fibrosis. Journal of Cystic Fibrosis 2011;10(5):350‐6. [PUBMED: 21632288]
Vecht J, Symersky T, Lamers CB, Masclee AA. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency. Journal of Clinical Gastroenterology 2006;40(8):721‐5. [PUBMED: 16940886]
Vujasinovic M, Valente R, Del Chiaro M, Permert J, Lohr JM. Pancreatic exocrine insufficiency in pancreatic cancer. Nutrients 2017;9(3):183. [PUBMED: 28241470]
Wells JS, Strickland OL, Dalton JA, Freeman S. Adherence to intravenous chemotherapy in African American and white women with early‐stage breast cancer. Cancer Nursing 2015;38(2):89‐98.
Whitcomb DC, Lehman GA, Vasileva G, Malecka‐Panas E, Gubergrits N, Shen Y, et al. Pancrelipase delayed‐release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double‐blind randomized trial. American Journal of Gastroenterology 2010;105(10):2276‐86.
Yuasa Y, Murakami Y, Nakamura H, Uemura K, Ohge H, Sudo T, et al. Histological loss of pancreatic exocrine cells correlates with pancreatic exocrine function after pancreatic surgery. Pancreas 2012;41(6):928‐33. [PUBMED: 22781909]
